(Allow video to load after clicking play)
Medtronic agreed to buy Covidien Plc for $42.9 billion in cash and stock as it transforms into a broader-based company bolstered by new tax advantages. Bloomberg's Zach Mider and David Welch on Bloomberg Television's "Taking Stock." (Source: Bloomberg June 16)
